Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAS-mutant Colorectal Cancer”

45 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 45 results

Early research (Phase 1)Looking for participantsNCT07349537
What this trial is testing

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Adenocarcinoma+7 more
Revolution Medicines, Inc. 574
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06835179
What this trial is testing

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

Who this might be right for
Unresectable Metastatic Colorectal CancerMicrosatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 28
Testing effectiveness (Phase 2)Study completedNCT01394939
What this trial is testing

Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma

Who this might be right for
Colorectal CarcinomaCRC
Jennerex Biotherapeutics 52
Testing effectiveness (Phase 2)UnknownNCT01190462
What this trial is testing

Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Leiden University Medical Center 51
Early research (Phase 1)Ended earlyNCT06194877
What this trial is testing

Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

Who this might be right for
Colorectal CancerPancreatic Ductal CancerAdvanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers
MapKure, LLC 13
Large-scale testing (Phase 3)UnknownNCT04781270
What this trial is testing

MFOLFOXIRI+Bev vs. mFOLFOX6+Bev for RAS Mutant Unresectable Colorectal Liver-limited Metastases

Who this might be right for
Colorectal CarcinomaLiver Metastases
Fudan University 308
Early research (Phase 1)Study completedNCT02510001
What this trial is testing

MEK and MET Inhibition in Colorectal Cancer

Who this might be right for
Solid TumorColorectal Cancer
University of Oxford 82
Testing effectiveness (Phase 2)UnknownNCT05522738
What this trial is testing

Safety and Efficacy of Fruquintinib+FOLFIRI in RAS-mutated Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Chinese PLA General Hospital 46
Testing effectiveness (Phase 2)UnknownNCT04653480
What this trial is testing

Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC

Who this might be right for
Colorectal Cancer
Zhejiang University 61
Testing effectiveness (Phase 2)UnknownNCT01110785
What this trial is testing

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Leiden University Medical Center 46
Testing effectiveness (Phase 2)Looking for participantsNCT06206096
What this trial is testing

PD-1 Antibody Plus Bevacizumab and CAPOX as First-line Treatment for RAS-mut MSS mCRC

Who this might be right for
Colorectal CancerRAS MutationColorectal Neoplasms+1 more
Chinese PLA General Hospital 40
Large-scale testing (Phase 3)WithdrawnNCT01646554
What this trial is testing

Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases

Who this might be right for
Colorectal Cancer MetastaticLiver MetastasesKRAS Mutated Colorectal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07198321
What this trial is testing

A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors

Who this might be right for
CancerPDACCRC (Colorectal Cancer)+1 more
Genfleet Therapeutics (Shanghai) Inc. 450
Testing effectiveness (Phase 2)UnknownNCT05842525
What this trial is testing

Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hunan Cancer Hospital 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07007728
What this trial is testing

Iparomlimab/Tuvonralimab Combined With Bevacizumab and CAPEOX as Conversion Therapy for Colorectal Cancer Liver Metastasis

Who this might be right for
Colorectal NeoplasmsSecondary Malignant Neoplasm of Liver
Peking University Cancer Hospital & Institute 54
Not applicableUnknownNCT04852250
What this trial is testing

Centralized Tumour Board and Secondary Intervention Rate in mCRC

Who this might be right for
Metastatic Colorectal CancerRAS MutationMultidisciplinary Communication+1 more
Ludwig-Maximilians - University of Munich 130
Not applicableStudy completedNCT03010722
What this trial is testing

Prospective Translational Study Investigating Molecular Predictors of Resistance and Response to Regorafenib Monotherapy

Who this might be right for
Metastatic Colorectal Cancer
Royal Marsden NHS Foundation Trust 49
Early research (Phase 1)UnknownNCT04303403
What this trial is testing

Study of Trametinib and Ruxolitinib in Colorectal Cancer and Pancreatic Adenocarcinoma

Who this might be right for
Colorectal CancerPancreatic Adenocarcinoma
National Cancer Centre, Singapore 48
Early research (Phase 1)Study completedNCT03597581
What this trial is testing

RGX-202-01 (Ompenaclid) as Combination Therapy in RAS Mutant Advanced Colorectal Cancer

Who this might be right for
Gastrointestinal CancerGastrointestinal NeoplasmsColorectal Cancer+7 more
Inspirna, Inc. 89
Not applicableStudy completedNCT01822444
What this trial is testing

ANGIOPREDICT. ICORG 12-16, V3

Who this might be right for
Advanced Colorectal Cancer
Cancer Trials Ireland 76
Load More Results